Skip to main content
. 2024 Feb 6;16(4):680. doi: 10.3390/cancers16040680

Figure 3.

Figure 3

Molecular pathways that involve the role of CSCs in topo-active drug resistance. Cancer stem cells (CSCs), topoisomerase-active drugs (topo-active drugs), and tumor microenvironment (TME).